Default-mode-like network activation in awake rodents.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 3220684)

Published in PLoS One on November 18, 2011

Authors

Jaymin Upadhyay1, Scott J Baker, Prasant Chandran, Loan Miller, Younglim Lee, Gerard J Marek, Unal Sakoglu, Chih-Liang Chin, Feng Luo, Gerard B Fox, Mark Day

Author Affiliations

1: Translational Sciences, Advanced Technology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois, United States of America. jaymin.upadhyay@abbott.com

Articles citing this

Deep impact: unintended consequences of journal rank. Front Hum Neurosci (2013) 2.78

Large-scale brain networks in the awake, truly resting marmoset monkey. J Neurosci (2013) 1.00

Connectivity trajectory across lifespan differentiates the precuneus from the default network. Neuroimage (2013) 0.98

Monkey in the middle: why non-human primates are needed to bridge the gap in resting-state investigations. Front Neuroanat (2012) 0.97

Large-scale topology and the default mode network in the mouse connectome. Proc Natl Acad Sci U S A (2014) 0.96

Dynamic repertoire of intrinsic brain states is reduced in propofol-induced unconsciousness. Brain Connect (2014) 0.95

Multiphasic modification of intrinsic functional connectivity of the rat brain during increasing levels of propofol. Neuroimage (2013) 0.95

Mapping brain metabolic connectivity in awake rats with μPET and optogenetic stimulation. J Neurosci (2013) 0.88

Functional magnetic resonance imaging of intrinsic brain networks for translational drug discovery. Trends Pharmacol Sci (2014) 0.87

Anti-correlated cortical networks of intrinsic connectivity in the rat brain. Brain Connect (2013) 0.86

Functional ultrasound imaging of intrinsic connectivity in the living rat brain with high spatiotemporal resolution. Nat Commun (2014) 0.84

Considerations for resting state functional MRI and functional connectivity studies in rodents. Front Neurosci (2015) 0.82

Default mode network, motor network, dorsal and ventral basal ganglia networks in the rat brain: comparison to human networks using resting state-fMRI. PLoS One (2015) 0.81

The power of using functional fMRI on small rodents to study brain pharmacology and disease. Front Pharmacol (2015) 0.80

Gabapentin reverses central hypersensitivity and suppresses medial prefrontal cortical glucose metabolism in rats with neuropathic pain. Mol Pain (2014) 0.78

Targeting Functional Biomarkers in Schizophrenia with Neuroimaging. Curr Pharm Des (2016) 0.77

Functional Connectivity Hubs and Networks in the Awake Marmoset Brain. Front Integr Neurosci (2016) 0.77

Analysis of coherent activity between retrosplenial cortex, hippocampus, thalamus, and anterior cingulate cortex during retrieval of recent and remote context fear memory. Neurobiol Learn Mem (2015) 0.76

Novel method for functional brain imaging in awake minimally restrained rats. J Neurophysiol (2016) 0.76

Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline. Front Aging Neurosci (2016) 0.75

The Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats. Front Behav Neurosci (2016) 0.75

Characterization of Structural Connectivity of the Default Mode Network in Dogs using Diffusion Tensor Imaging. Sci Rep (2016) 0.75

BOLD fMRI in awake prairie voles: A platform for translational social and affective neuroscience. Neuroimage (2016) 0.75

Spatial patterns of neuronal activity in rat cerebral cortex during non-rapid eye movement sleep. Brain Struct Funct (2014) 0.75

Articles cited by this

A default mode of brain function. Proc Natl Acad Sci U S A (2001) 50.73

Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A (2002) 31.14

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A (2004) 19.84

Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A (2006) 19.60

Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22

Intrinsic functional architecture in the anaesthetized monkey brain. Nature (2007) 14.47

Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage (2008) 12.12

Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69

Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb Cortex (2008) 9.38

Subgenual prefrontal cortex abnormalities in mood disorders. Nature (1997) 9.36

Bayesian analysis of neuroimaging data in FSL. Neuroimage (2008) 9.10

Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry (1999) 7.87

Aberrant "default mode" functional connectivity in schizophrenia. Am J Psychiatry (2007) 7.08

Brain work and brain imaging. Annu Rev Neurosci (2006) 6.99

Competition between functional brain networks mediates behavioral variability. Neuroimage (2007) 6.98

Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A (2009) 6.09

Neural mechanisms of autonomic, affective, and cognitive integration. J Comp Neurol (2005) 5.86

The integration of negative affect, pain and cognitive control in the cingulate cortex. Nat Rev Neurosci (2011) 5.79

Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav Brain Sci (1999) 5.12

Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology (2010) 5.07

How default is the default mode of brain function? Further evidence from intrinsic BOLD signal fluctuations. Neuropsychologia (2006) 4.58

Breakdown of within- and between-network resting state functional magnetic resonance imaging connectivity during propofol-induced loss of consciousness. Anesthesiology (2010) 3.55

Beyond feeling: chronic pain hurts the brain, disrupting the default-mode network dynamics. J Neurosci (2008) 3.41

Efferent connections of the cingulate gyrus in the rhesus monkey. Exp Brain Res (1981) 2.04

Comparative analysis of ACTH and corticosterone sampling methods in rats. Am J Physiol Endocrinol Metab (2005) 2.02

Direct and indirect pathways from the amygdala to the frontal lobe in rhesus monkeys. J Comp Neurol (1981) 2.00

Functional magnetic resonance imaging in conscious animals: a new tool in behavioural neuroscience research. J Neuroendocrinol (2006) 1.69

A comparison of resting-state brain activity in humans and chimpanzees. Proc Natl Acad Sci U S A (2007) 1.65

Uncovering intrinsic connectional architecture of functional networks in awake rat brain. J Neurosci (2011) 1.57

Mapping resting-state brain networks in conscious animals. J Neurosci Methods (2010) 1.54

Dose-dependent effect of isoflurane on neurovascular coupling in rat cerebral cortex. Eur J Neurosci (2009) 1.49

Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD. Ann N Y Acad Sci (1997) 1.39

The process of awakening: a PET study of regional brain activity patterns mediating the re-establishment of alertness and consciousness. Brain (2002) 1.34

Neural substrates linking balance control and anxiety. Physiol Behav (2002) 1.16

The posterior hypothalamic area: chemoarchitecture and afferent connections. Brain Res (2001) 1.09

Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures. J Neurosci (2011) 1.08

GABA receptors in the posterior hypothalamus regulate experimental anxiety in rats. Brain Res (1990) 0.95

Limbic thalamic lesions, appetitively motivated discrimination learning, and training-induced neuronal activity in rabbits. J Neurosci (2002) 0.91

Hippocampal inputs mediate theta-related plasticity in anterior thalamus. Neuroscience (2011) 0.86

Effects of learned helplessness on brain GABA receptors. Neurosci Res (2000) 0.84

Dopamine receptors and learned helplessness in the rat: an autoradiographic study. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.84

Functional roles of the monoaminergic and aminoacidergic mechanisms of the dorsal pallidum in anxiety of different aversive origins. Neurosci Behav Physiol (2008) 0.81

Direct projections of the hypothalamic nuclei to the thalamic mediodorsal nucleus in the cat. Neurosci Lett (1985) 0.77

Articles by these authors

Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci (2008) 2.29

A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther (2006) 2.06

Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J Neurosci (2008) 2.04

Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS One (2008) 1.91

Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain (2009) 1.84

Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol (2006) 1.82

ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities. J Pharmacol Exp Ther (2008) 1.81

Electrophysiological and in vivo characterization of A-317567, a novel blocker of acid sensing ion channels. Pain (2005) 1.46

Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies. Alzheimers Res Ther (2011) 1.43

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease. J Alzheimers Dis (2015) 1.43

Functional molecular ecological networks. MBio (2010) 1.37

Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia? Curr Drug Targets CNS Neurol Disord (2002) 1.36

Spatial correlations of laminar BOLD and CBV responses to rat whisker stimulation with neuronal activity localized by Fos expression. Magn Reson Med (2004) 1.35

Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation. Pain (2011) 1.34

An image-based finite difference model for simulating restricted diffusion. Magn Reson Med (2003) 1.34

Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale (2011) 1.32

Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain? Mol Pharmacol (2009) 1.29

Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.29

Population genetics and linkage analysis of loci within the FCT region of Streptococcus pyogenes. J Bacteriol (2006) 1.28

Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke. J Cereb Blood Flow Metab (2007) 1.26

MRI diffusion coefficients in spinal cord correlate with axon morphometry. Neuroreport (2005) 1.25

The association of multiple interacting genes with specific phenotypes in rice using gene coexpression networks. Plant Physiol (2010) 1.25

Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke. J Neurochem (2008) 1.24

Discrete surface Ricci flow. IEEE Trans Vis Comput Graph (2008) 1.23

Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system. Int J Pharm (2009) 1.23

Metabotropic glutamate receptors in the control of mood disorders. CNS Neurol Disord Drug Targets (2007) 1.23

Hemodynamic and metabolic changes induced by cocaine in anesthetized rat observed with multimodal functional MRI. Psychopharmacology (Berl) (2006) 1.21

Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo. Microbiology (2002) 1.21

Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. Br J Pharmacol (2011) 1.20

A high density consensus genetic map of tetraploid cotton that integrates multiple component maps through molecular marker redundancy check. PLoS One (2012) 1.20

Evolution of transcription regulatory genes is linked to niche specialization in the bacterial pathogen Streptococcus pyogenes. J Bacteriol (2005) 1.19

Molecular ecological network analyses. BMC Bioinformatics (2012) 1.19

Phylogenetic molecular ecological network of soil microbial communities in response to elevated CO2. MBio (2011) 1.18

Role of streptococcal T antigens in superficial skin infection. J Bacteriol (2006) 1.18

Laparoscopic liver resection and the learning curve: a 14-year, single-center experience. Surg Endosc (2014) 1.15

Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders. Mol Interv (2006) 1.13

Midbrain activation during Pavlovian conditioning and delusional symptoms in schizophrenia. Arch Gen Psychiatry (2010) 1.11

Transient relationships among BOLD, CBV, and CBF changes in rat brain as detected by functional MRI. Magn Reson Med (2002) 1.11

Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot Cell (2007) 1.11

Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood (2003) 1.11

Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel. Int J Pharm (2008) 1.11

Perpendicular magnetic anisotropy induced by tetragonal distortion of FeCo alloy films grown on Pd(001). Phys Rev Lett (2006) 1.10

Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys (2007) 1.08

A quantitative genotype algorithm reflecting H5N1 Avian influenza niches. Bioinformatics (2007) 1.07

Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity. J Med Chem (2010) 1.07

Diagnosis prevention and treatment for PICC-related upper extremity deep vein thrombosis in breast cancer patients. Asia Pac J Clin Oncol (2012) 1.07

Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule. Neurosci Biobehav Rev (2005) 1.06

Whole-genome association study on tissue tropism phenotypes in group A Streptococcus. J Bacteriol (2011) 1.06

How many dendritic cells are required to initiate a T-cell response? Blood (2012) 1.06

Apparent diffusion coefficients in spinal cord transplants and surrounding white matter correlate with degree of axonal dieback after injury in rats. AJNR Am J Neuroradiol (2005) 1.05

Characterization of the Shewanella oneidensis Fur gene: roles in iron and acid tolerance response. BMC Genomics (2008) 1.04

Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039). J Pharmacol Exp Ther (2007) 1.03

N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes. J Pharmacol Exp Ther (2010) 1.03

Preventing postoperative abdominal adhesions in a rat model with PEG-PCL-PEG hydrogel. Int J Nanomedicine (2012) 1.02

Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro. Int J Pharm (2009) 1.02

H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacol Biochem Behav (2009) 1.01

Ex vivo evaluation of ADC values within spinal cord white matter tracts. AJNR Am J Neuroradiol (2005) 1.01

Snapshot of iron response in Shewanella oneidensis by gene network reconstruction. BMC Genomics (2009) 1.01

Building a scientific framework for studying hormonal effects on behavior and on the development of the sexually dimorphic nervous system. Neurotoxicology (2008) 1.00

WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. Neuropharmacology (2008) 1.00

Preparation of curcumin loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells. Nanoscale (2011) 1.00

Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging. J Pharmacol Exp Ther (2008) 0.99

Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor. J Immunol (2003) 0.99

The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice. Behav Brain Res (2009) 0.99

Differential responses in CBF and CBV to cocaine as measured by fMRI: implications for pharmacological MRI signals derived oxygen metabolism assessment. J Psychiatr Res (2009) 0.98

Hydrogen peroxide-induced oxidative stress responses in Desulfovibrio vulgaris Hildenborough. Environ Microbiol (2010) 0.97

Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization. Nanotechnology (2010) 0.97

Comparison of mechanical allodynia and the affective component of inflammatory pain in rats. Neuropharmacology (2009) 0.97

Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease. Neurobiol Aging (2010) 0.96

Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine. Biochem Pharmacol (2011) 0.96

Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties. CNS Neurosci Ther (2008) 0.96

A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model. Pain (2010) 0.96

Quercetin attenuates airway inflammation and mucus production induced by cigarette smoke in rats. Int Immunopharmacol (2012) 0.96

Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases. Cancer (2009) 0.96

Neuroprotective and nootropic actions of a novel cyclized dipeptide after controlled cortical impact injury in mice. J Cereb Blood Flow Metab (2003) 0.95

Enhanced reduction in hyperalgesia by combined administration of clonidine and TENS. Pain (2002) 0.94

Antisense knockdown of the rat alpha7 nicotinic acetylcholine receptor produces spatial memory impairment. Neurosci Lett (2006) 0.94

Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles. Pharm Res (2009) 0.94

Polymeric matrix for drug delivery: honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel. J Biomed Mater Res A (2010) 0.94

The 5-HT(2C) receptor agonist WAY-163909 decreases impulsivity in the 5-choice serial reaction time test. Behav Brain Res (2007) 0.94

CNS distribution of metabotropic glutamate 2 and 3 receptors: transgenic mice and [³H]LY459477 autoradiography. Neuropharmacology (2012) 0.94

Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice. J Biol Chem (2003) 0.93

Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro. Int J Pharm (2009) 0.93

Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects. J Pharmacol Exp Ther (2003) 0.93

PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery. Curr Drug Targets (2011) 0.93

Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors. Clin Cancer Res (2005) 0.93

Large-scale synthesis of single-crystalline iron oxide magnetic nanorings. J Am Chem Soc (2008) 0.92

Polysorbate 80 coated poly (ɛ-caprolactone)-poly (ethylene glycol)-poly (ɛ-caprolactone) micelles for paclitaxel delivery. Int J Pharm (2012) 0.92

Perspectives on cognitive domains, H3 receptor ligands and neurological disease. Expert Opin Investig Drugs (2004) 0.92

A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats. Pharmacol Biochem Behav (2005) 0.92

A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healing. Biomaterials (2013) 0.92

Urothelial carcinomas: a focus on human epidermal receptors signaling. Am J Transl Res (2011) 0.92

Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery. J Phys Chem B (2009) 0.92

Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites. Nanoscale (2012) 0.92

High-frequency sonographic measurements of true and false vocal cords. J Ultrasound Med (2010) 0.92

Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties. J Pharmacol Exp Ther (2004) 0.91